Appen Limited

APX

Appen Ltd. engages in the development of human-annotated datasets for machine learning and artificial intelligence. The company is headquartered in Chatswood, New South Wales and currently employs 1,130 full-time employees. The company went IPO on 2015-01-07. The firm is engaged in providing data services for deep learning and generative artificial intelligence (AI) systems. The firm operates through two segments: Global Services and New Markets. The Global Services represent the services that the Company provides to its five United States technology customers (Global customers) using the customer's data annotation platforms and tools. New Markets comprise Appen's data annotation platform and tools (Global Product), and the enterprise, government, and China business units. New Markets also include Quadrant geolocation and Point-of-Interest (POI) data capabilities. Its Annotation Platform is the platform that both customers and internal teams used to design, run and manage data annotation tasks. The firm serves various industries, including technology, automotive, financial services, healthcare, retail, and government agencies.

Arafura Rare Earths Ltd

ARU

Arafura Rare Earths Ltd. engages in the exploration and development of mineral resource properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-11-05. The firm produces rare earth products from the Nolans Project. The Nolans Project consists of a mine, process plant, including beneficiation, extraction and separation plants, and related infrastructure to be constructed and located at the Nolans site, approximately 135 kilometers north of Alice Springs in Australia's Northern Territory. Its rare earth products are Neodymium-Praseodymium (NdPr) oxide, and Mixed middle-heavy rare earths (SEG/HRE) oxide. NdPr oxide is the Company's flagship product, which is used by magnet and magnet alloy customers. The Company’s primary products from the Nolans project are rare earths, which are used in catalytic converters in automobiles, consumer electronics, energy efficiency lighting, optics, alloys, advanced ceramics and permanent magnets that enable e-mobility and renewable energy applications.

Bapcor Limited

BAP

Bapcor Ltd. engages in the business of selling and distributing vehicle parts, accessories, automotive equipment, service, and solutions. The company is headquartered in Melbourne, Victoria and currently employs 5,100 full-time employees. The company went IPO on 2014-04-24. The Company’s segments include Trade, Specialist Wholesale, Retail and New Zealand. The Trade segment represents the trade-focused automotive aftermarket parts distribution to independent and chain mechanic workshops. The company also includes the operations of Burson Auto Parts, Precision Automotive Equipment, Blacktown Auto and the Thailand-based operation. The Specialist Wholesale segment includes specialized wholesale distribution and network channel areas that focus on a specific automotive area, such as AAD, Baxters, Bearing Wholesalers, Roadsafe, Diesel Distributors, Federal Batteries, JAS, Premier Auto Trade, Truckline and WANO. The Retail segment includes operations of Autobarn, Autopro, Midas, ABS and Opposite Lock. The Retail segment is a full-offer retailer and service center. The New Zealand includes operations of Brake & Transmission (BNT), Autolign and HCB Technologies.

Botanix Pharmaceuticals Ltd

BOT

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

Air New Zealand Limited

AIZ

Air New Zealand Ltd. engages in the transportation of passengers and cargo on an integrated network of scheduled airline services. Its geographical segments include New Zealand, Australia and Pacific Islands, Asia, the United Kingdom and Europe, and America. The firm has approximately 104 operating aircraft ranging from Boeing 787-9 Dreamliners and Airbus A320s to ATRs and Q300s, offering customers. The company has domestic business, connecting customers and cargo to over 20 different regions around New Zealand. Internationally, the airline has direct flights to cities across Australia, Asia, the Pacific Islands, and the United States. Its operating fleet includes Boeing 777-300ER, Boeing 787-9 Dreamliner, AirbusA321neo, AirbusA320neo, AirbusA320ceo, ATR 72-600, and Bombardier Q300. The company is a supplier of aircraft, and component maintenance, repair, and overhaul (MRO) services to customers in New Zealand, Australia, Asia, the Americas, and Europe.